Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05882890 · OUTCOME

Number of Partcipants Who Experienced a Decrease in Symptoms With Their Late Sequela the 5. Time of Treatment

Does Craniosacraltherapy Combined With Exercises That Focuses om Respiration and Posture in the Upper Body Have an Effect on Xerostomia and Other Late Sequelae on People Who Has Been Suffering From Cancer in Mouth and Throat? · Source last updated 2026-06-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
The 5. and last time of treatment(intervention of this study)

What was measured

A history is taken before the first treatment, where I asked if the participant suffered from 11 other well-known late sequela. At the 5. and last treatment I asked then if they observed any changes in their late seguela (better or worse) - They did not report any worsening of their late sequela, but a number of participants reported some positive changes.The selfreported change in symptoms is noted in their patient record. The following is the number of participants, who observed a positive change( a decrease in symptoms) in their late sequeale.

Analysis population: 11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale

Groups in this outcome

Cranoisacral Therapy Receivers

The participants will receive 50 minutes treatment of craniosacral therapy weekly in 5 weeks. The treatment will follow the protocol "avenue of expression" and step 2c and 2c in "Ten step protocol". They will get instructions in exercises targeting the upper posture and respiration to do at home. Before treatment the participants fill in the questionnaire " Xerostomia questionnaire after 3 months" - a danish standardized questionnaire of xerostomia used of hospitals. They will fulfill this questionnaire again after ending their 5 treatment sessions, and again 6 months later as a follow up. They will also fill in a diary with any side effects experienced during the treatment period. I will take their full history the first time we meet. I journalize my treatment after every treatment session, and note which effects (positive and negative) the participant has noticed. cranio sacral therapy: Manual treatment of 5 grams on the whole airway system, the throat, the neck, the meninges, the cranium, nerve sleeves, the visceral cranium, the soft tissue in the mouth. exercises- targeting the upper posture and respiration.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cranoisacral Therapy Receivers10

Reported measurements

dry mouth
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers2Not reportedNot reportedNot reportedNot reported
obstipation
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers2Not reportedNot reportedNot reportedNot reported
lymphedema
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers0Not reportedNot reportedNot reportedNot reported
tinnitus
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers0Not reportedNot reportedNot reportedNot reported
difficulty swallowing
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers1Not reportedNot reportedNot reportedNot reported
tense/stiff neck
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers3Not reportedNot reportedNot reportedNot reported
problems with respiration
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers4Not reportedNot reportedNot reportedNot reported
stiff jaw
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers0Not reportedNot reportedNot reportedNot reported
difficulty with speaking
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers0Not reportedNot reportedNot reportedNot reported
fatigue
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers1Not reportedNot reportedNot reportedNot reported
difficulty sleeping
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers2Not reportedNot reportedNot reportedNot reported
pain
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cranoisacral Therapy Receivers0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2
    title
    dry mouth
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        2
    title
    obstipation
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    lymphedema
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    tinnitus
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    difficulty swallowing
  6. categories
    1. measurements
      1. group Id
        OG000
        value
        3
    title
    tense/stiff neck
  7. categories
    1. measurements
      1. group Id
        OG000
        value
        4
    title
    problems with respiration
  8. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    stiff jaw
  9. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    difficulty with speaking
  10. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    fatigue
  11. categories
    1. measurements
      1. group Id
        OG000
        value
        2
    title
    difficulty sleeping
  12. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    pain
denoms
  1. counts
    1. group Id
      OG000
      value
      10
    units
    Participants
description
A history is taken before the first treatment, where I asked if the participant suffered from 11 other well-known late sequela. At the 5. and last treatment I asked then if they observed any changes in their late seguela (better or worse) - They did not report any worsening of their late sequela, but a number of participants reported some positive changes.The selfreported change in symptoms is noted in their patient record. The following is the number of participants, who observed a positive change( a decrease in symptoms) in their late sequeale.
groups
  1. description
    The participants will receive 50 minutes treatment of craniosacral therapy weekly in 5 weeks. The treatment will follow the protocol "avenue of expression" and step 2c and 2c in "Ten step protocol". They will get instructions in exercises targeting the upper posture and respiration to do at home. Before treatment the participants fill in the questionnaire " Xerostomia questionnaire after 3 months" - a danish standardized questionnaire of xerostomia used of hospitals. They will fulfill this questionnaire again after ending their 5 treatment sessions, and again 6 months later as a follow up. They will also fill in a diary with any side effects experienced during the treatment period. I will take their full history the first time we meet. I journalize my treatment after every treatment session, and note which effects (positive and negative) the participant has noticed. cranio sacral therapy: Manual treatment of 5 grams on the whole airway system, the throat, the neck, the meninges, the cranium, nerve sleeves, the visceral cranium, the soft tissue in the mouth. exercises- targeting the upper posture and respiration.
    id
    OG000
    title
    Cranoisacral Therapy Receivers
param Type
NUMBER
population Description
11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale
reporting Status
POSTED
time Frame
The 5. and last time of treatment(intervention of this study)
title
Number of Partcipants Who Experienced a Decrease in Symptoms With Their Late Sequela the 5. Time of Treatment
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice